G9452 HCV Test Omission - HCPCS Reimbursement | OpenPayer

Summary & Overview

HCPCS G9452: Documentation of Not Performing HCV Antibody Test Due to Limited Life Expectancy

HCPCS Level II code G9452 records documentation that an HCV antibody test was not performed because of the patient’s limited life expectancy. The code captures a clinical decision to forgo hepatitis C antibody screening when prognosis renders testing and potential subsequent interventions unlikely to benefit the patient. Nationally, this code matters for quality measurement, reporting of screening exceptions, and accurate capture of reasons for nonperformance of preventive services.

Key payers in this coverage context include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what G9452 denotes, how it is used across care settings, and what to expect in payer policies and documentation standards. The publication outlines benchmarking considerations for exception reporting, implications for quality measurement and claims processing, and the clinical context in which documentation of limited life expectancy may be appropriate.

This analysis provides guidance on interpretation and operational use (documentation expectations, typical sites of service) rather than clinical decision-making. Data not available in the input is noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG9452HCPCS Level IIHCV antibodyscreening exceptionpreventive servicesdocumentationquality measurementclaims reporting

Billing Code Overview

HCPCS Level II code G9452 documents the medical reason(s) for not receiving an HCV antibody test due to limited life expectancy. This code indicates that a clinician recorded clinical justification that a patient will not undergo hepatitis C virus (HCV) antibody screening because the patient’s limited life expectancy makes testing clinically inappropriate.

Service type: Clinical documentation of testing omission for HCV screening based on prognosis
Typical site of service: Outpatient clinic or inpatient setting where HCV screening decisions and documentation are made

Clinical & Coding Specifications

Clinical Context

A patient with advanced, terminal illness (for example, metastatic pancreatic cancer receiving palliative care or end-stage heart failure with progressive decline) presents to an outpatient primary care clinic, hospice, or inpatient palliative care service. The clinical team evaluates preventive screening needs including hepatitis C virus (HCV) antibody testing. Given the patient’s limited life expectancy and goals of care focused on comfort rather than diagnostic evaluation or antiviral therapy, the clinician documents medical reasons for not performing the HCV antibody test. Documentation includes the patient’s prognosis, discussion with the patient and/or authorized surrogate about goals of care, and a clear statement that HCV testing is not expected to change management due to limited life expectancy. This documentation supports billing of G9452 (Documentation of medical reason(s) for not receiving hcv antibody test due to limited life expectancy). Typical workflow: medical assessment and prognosis documentation, goals-of-care discussion, recording rationale in the medical record, and submission of the G9452 code with the encounter. Typical sites of service include outpatient primary care clinics, hospice facilities, inpatient hospital wards, and palliative care clinics. A realistic patient scenario: an 82-year-old with metastatic lung cancer, declining performance status, and a documented expected survival measured in weeks to a few months; clinician documents that HCV antibody testing is not indicated because results would not alter treatment or comfort-focused goals of care. Common modifiers that may accompany the claim include 23, 52, 53, 55, and billing or payer-specific modifiers for facility or provider identifiers.

Coding Specifications

HCPCS G2161: Prior Adverse Reaction to Zoster Vaccine

HCPCS-G1011-CLINICAL-DECISION-SUPPORT-TOOL-APPROPRIATE-USE

HCPCS G1011: Clinical Decision Support Mechanism, Qualified Tool

HCPCS-G9956-PERIOPERATIVE-COMBINATION-ANTIEMETIC-PROPHYLAXIS

HCPCS G9956: Perioperative Combination Antiemetic Prophylaxis

HCPCS-G0051-HOSPICE-PATIENT-REPORTING-CURRENT-MONTH

HCPCS G0051: Patients Under Hospice Care in Reporting Month

HCPCS-G9306-ANASTOMOTIC-LEAK-INTERVENTION

HCPCS G9306: Intervention for Anastomotic Leak

HCPCS-G9236-OPTIMIZING-PATIENT-EXPOSURE-IONIZING-RADIATION-MEASURES-COMPLETED

HCPCS G9236: Optimization of Patient Exposure to Ionizing Radiation

HCPCS-G9552-INCIDENTAL-THYROID-NODULE-SUBCENTIMETER

HCPCS G9552: Incidental Thyroid Nodule <1.0 cm Noted in Report

HCPCS-G8815-STATIN-THERAPY-OMISSION-DOCUMENTED-REASON

HCPCS G8815: Documented Reason for Not Prescribing Statin Therapy

HCPCS-G9778-PREGNANCY-DIAGNOSIS-MEASUREMENT-PERIOD

HCPCS G9778: Pregnancy Diagnosis During Measurement Period

HCPCS-G8573-STROKE-FOLLOWING-ISOLATED-CABG-SURGERY

HCPCS G8573: Stroke Following Isolated CABG Surgery

Showing 1–10 of 1996

Modifier	Description	When to Use
`22`	Increased procedural services	Use when additional documentation supports substantially greater physician work or complexity related to the encounter documentation beyond typical time/effort.
`23`	Unusual anesthesia	Use when general anesthesia was medically necessary for the encounter (rare for documentation-only services) and must be reported with supporting documentation.
`52`	Reduced services	Use when elements of the encounter or service were intentionally reduced or partially performed.
`53`	Discontinued procedure	Use when the planned service was started but terminated due to patient condition or other clinical reasons.
`54`	Surgical care only	Use if the billing episode is limited to surgical care; rarely applicable but included when documentation-only claims are linked to surgical encounters.
`55`	Postoperative management only	Use when only postoperative care is billed for the episode and documentation pertains to ongoing management decisions.
`56`	Preoperative management only	Use when only preoperative evaluation and management is provided and documentation justifies omission of testing.
`62`	Two surgeons	Use when two surgeons of different specialties are involved in the same operative session that informs the decision not to test.
`AS`	Local anesthesia	Use when the encounter included regional/local anesthesia that impacts the service delivery.
`QK`	Medical direction of two, three, or four assistants at surgery	Use when documentation indicates assistant-at-surgery medical direction that relates to the episode of care.

Taxonomy Code	Specialty	Notes
`207Q00000X`	Family Medicine	Primary outpatient providers who document screening decisions and prognosis.
`207P00000X`	Internal Medicine	Hospitalists and outpatient internists making testing decisions in complex medically ill adults.
`261QM0800X`	Hospice and Palliative Medicine	Specialists who commonly document limited life expectancy and decisions to forgo screening.
`207L00000X`	Oncology	Oncology clinicians documenting that screening is not appropriate in terminal cancer.
`207K00000X`	Geriatric Medicine	Providers assessing frailty, life expectancy, and appropriateness of preventive testing.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`Z51.5`	Encounter for palliative care	Indicates palliative focus of care and supports documentation that HCV antibody testing is not appropriate given limited life expectancy.
`Z51.89`	Encounter for other specified aftercare	Used when ongoing supportive care or aftercare planning affects decisions about preventive screening.
`C78.7`	Secondary malignant neoplasm of liver and intrahepatic bile duct	Example metastatic disease with limited prognosis where HCV testing would not change management.
`C80.1`	Malignant (primary) neoplasm, unspecified; metastatic disease, unspecified	Advanced malignancy often associated with limited life expectancy and rationale to defer HCV testing.
`I50.84`	End stage heart failure	Advanced cardiac disease with limited life expectancy; supports decision to withhold nonbeneficial screening.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99304`	Initial nursing facility care, per day, for evaluation and management of a new or established patient	May be performed when documenting medical reasons for not pursuing HCV testing in a nursing facility resident with limited life expectancy.
`99223`	Initial hospital care, typically 70 minutes or more	Used for comprehensive inpatient evaluation where prognosis and decisions about diagnostic testing are documented.
`99377`	Physician supervision of hospice care, likely per diem (example for reporting ongoing hospice management)	Relates to hospice documentation and decisions to withhold screening tests such as HCV antibody testing.
`99497`	Advance care planning including documentation of an advance directive, first 30 minutes	Often accompanies goals-of-care discussions that support the decision not to perform HCV testing.
`99406`	Smoking and tobacco use cessation counseling visit, intermediate, 3-10 minutes	Example supportive counseling that can occur during visits where preventive testing decisions are discussed.

OpenPayer